
Loading, please wait...

Loading, please wait...

India's largest standalone health insurer, Star Health and Allied Insurance, is launching a new product named Value Plus. This policy delivers affordable health insurance directly to tier-2, tier-3, and tier-4 cities across the country. Additionally, the new plan offers premiums that are approximately 20% lower than the company's existing products in these regions. Therefore, this strategic move aims to improve insurance penetration in markets where cost has traditionally been a significant barrier.
Anand Roy, the Managing Director and CEO of Star Health, emphasized that cost is a major hurdle in smaller towns. Consumer surveys show that high premiums frequently deter families from purchasing coverage. Consequently, the company designed this new product to retain essential mainstream features while keeping the prices lower. Specifically, the annual premiums for Value Plus will range between ₹15,000 and ₹16,000. Furthermore, the insurer expects this product to contribute around 10% of its future revenue.
Interestingly, the insurer decided to exclude metro cities from this budget-friendly offering. Healthcare inflation and hospital claims costs continue to rise significantly in metropolitan areas. In contrast, non-metro markets demonstrate greater structural profitability. For instance, loss ratios in smaller cities are currently running 4 to 5 percentage points lower than the company's overall average of 69%. Consequently, the lower operating costs in these regions allow the company to offer cheaper premiums without compromising on coverage quality.
The launch aligns with increasing insurance demand following the Indian government's GST waiver on health insurance premiums. This policy change has successfully driven higher renewals and improved persistency rates. Moreover, Star Health is expanding its distribution channel by appointing nearly one lakh new agents, with 80% of them operating in tier-2, tier-3, and tier-4 areas. To complement this, the insurer is rolling out \"Pratham,\" a preferred hospital network initiative. This program aims to minimize discharge delays and enhance patient satisfaction through direct hospital collaborations.
Q1: What is the new product launched by Star Health and Allied Insurance for non-metro cities?
Star Health has introduced an affordable health plan called Value Plus, targeting tier-2, tier-3, and tier-4 markets. This product offers premiums that are roughly 20% lower than existing policies while maintaining standard coverage features.
Q2: Why are metro cities excluded from this cheaper health insurance plan?
Metro cities face elevated healthcare inflation and higher hospital claim costs. In contrast, smaller cities have lower loss ratios, making them structurally more profitable and enabling lower premiums.
Q3: What is the \"Pratham\" initiative launched by Star Health?
Pratham is a preferred hospital network initiative designed by Star Health to improve the overall customer experience, minimize cashless discharge delays, and foster closer collaboration with select hospitals.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Star Health launches Value Plus, a 20% cheaper health cover for tier-2 and tier-3 cities in India to address affordability issues and boost penetration....
5 months ago

An elderly man with partially repaired Tetralogy of Fallot presented with STEMI caused by coronary embolism rather than atherosclerosis. Successful treatment with sustained mechanical aspiration thrombectomy underscores the vital need for high clinical vigilance in adult congenital heart disease.
Today

Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today

A recent study demonstrates that spinal oxygen sensors do not require mitochondrial electron transport to trigger sympathetic excitation during acute hypoxia, revealing new insights into how mitochondrial oxidative stress modulates autonomic tone in cardiovascular and neurological diseases.
Today

A novel calcium polyphosphate coacervate enables injectable bone implants with in situ hierarchical porosity via phase separation and gas foaming, significantly enhancing cell proliferation, energy metabolism, and osteogenic differentiation for minimally invasive bone defect repair.
Today

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today